• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向4-1BB及其配体的免疫疗法。

Immunotherapy targeting 4-1BB and its ligand.

作者信息

Vinay Dass S, Kwon Byoung S

机构信息

Department of Ophthalmology, LSU Eye Center, Louisiana State University Health Sciences Center School of Medicine, New Orleans, USA.

出版信息

Int J Hematol. 2006 Jan;83(1):23-8. doi: 10.1532/IJH97.05125.

DOI:10.1532/IJH97.05125
PMID:16443548
Abstract

T-cell activation in the absence of costimulation is futile because T-cells deprived of costimulatory signals enter a state of unresponsiveness or anergy. The interaction of 4-1BB and 4-1BB ligand (4-1BBL) activates an important costimulatory pathway with diverse and important roles in immune regulation. Signals relayed through 4-1BB generate strong CD8(+) T-cell responses rather than CD4(+) T-cell responses; this action results in cytokine induction and promotes T-cell survival. In recent years, 4-1BB-mediated immune regulation has gained great significance because of the seemingly contradictory dual roles of agonistic anti-4-1BB in vivo disease models. To date, agonistic 4-1BB monoclonal antibody has shown therapeutic potential against a variety of tumors, CD4(+) T-cell-mediated autoimmune diseases, and chronic graft-versus-host disease. In addition, blockade of 4-1BB/4-1BBL interaction has produced therapeutic effects against coxsackievirus-induced myocardial inflammation, herpetic stromal keratitis, and graft rejection. We propose that the dual roles of agonistic anti-4-1BB--an enhanced effector function and a suppressor function--are mediated by a novel CD11c(+)CD8(+) T-cell population.

摘要

在缺乏共刺激的情况下,T细胞激活是无效的,因为被剥夺共刺激信号的T细胞会进入无反应状态或失能状态。4-1BB与4-1BB配体(4-1BBL)的相互作用激活了一条重要的共刺激途径,在免疫调节中具有多种重要作用。通过4-1BB传递的信号产生强烈的CD8(+) T细胞反应而非CD4(+) T细胞反应;这种作用导致细胞因子诱导并促进T细胞存活。近年来,由于激动性抗4-1BB在体内疾病模型中看似矛盾的双重作用,4-1BB介导的免疫调节具有了重大意义。迄今为止,激动性4-1BB单克隆抗体已显示出对多种肿瘤、CD4(+) T细胞介导的自身免疫性疾病以及慢性移植物抗宿主病的治疗潜力。此外,阻断4-1BB/4-1BBL相互作用已对柯萨奇病毒诱导的心肌炎症、疱疹性基质性角膜炎和移植排斥产生了治疗效果。我们提出,激动性抗4-1BB的双重作用——增强的效应功能和抑制功能——是由一种新型的CD11c(+)CD8(+) T细胞群体介导的。

相似文献

1
Immunotherapy targeting 4-1BB and its ligand.靶向4-1BB及其配体的免疫疗法。
Int J Hematol. 2006 Jan;83(1):23-8. doi: 10.1532/IJH97.05125.
2
Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.阻断4-1BB(CD137)/4-1BB配体相互作用可提高同种异体移植物的存活率。
Transpl Int. 2004 Aug;17(7):351-61. doi: 10.1007/s00147-004-0726-3. Epub 2004 Jul 31.
3
Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.抗CD137抗体在自身免疫性疾病和癌症治疗中的应用。
Immunol Res. 2004;29(1-3):197-208. doi: 10.1385/IR:29:1-3:197.
4
Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.4-1BB(CDw137)的结扎调节异基因骨髓移植受者的移植物抗宿主病、移植物抗白血病和移植物排斥反应。
J Immunol. 2001 Mar 1;166(5):3174-83. doi: 10.4049/jimmunol.166.5.3174.
5
The therapeutic potential of 4-1BB (CD137) in cancer.4-1BB(CD137)在癌症治疗中的潜力。
Curr Cancer Drug Targets. 2005 Aug;5(5):357-63. doi: 10.2174/1568009054629681.
6
Role of 4-1BB in immune responses.4-1BB在免疫反应中的作用。
Semin Immunol. 1998 Dec;10(6):481-9. doi: 10.1006/smim.1998.0157.
7
4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.4-1BB可促进经抗CD45RB和抗CD40L单克隆抗体治疗的皮肤同种异体移植物的长期存活。
Transplant Proc. 2005 Jan-Feb;37(1):123-5. doi: 10.1016/j.transproceed.2005.01.016.
8
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.4-1BB共刺激信号优先诱导CD8 + T细胞增殖,并导致体内细胞毒性T细胞反应的扩增。
J Exp Med. 1997 Jul 7;186(1):47-55. doi: 10.1084/jem.186.1.47.
9
Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis.4-1BB(CD137)-4-1BB配体相互作用参与CD4 T细胞介导的炎症性结肠炎的调节
Clin Exp Immunol. 2006 Feb;143(2):228-36. doi: 10.1111/j.1365-2249.2005.02991.x.
10
4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.4-1BB配体介导的人T细胞共刺激可诱导CD4和CD8 T细胞扩增、细胞因子产生以及细胞溶解效应功能的发展。
J Immunol. 2002 May 15;168(10):4897-906. doi: 10.4049/jimmunol.168.10.4897.

引用本文的文献

1
Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications.4-1BB 激动剂在免疫治疗中的作用:对可能性和并发症的展望。
Front Immunol. 2023 Aug 17;14:1228486. doi: 10.3389/fimmu.2023.1228486. eCollection 2023.
2
An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer.抗 CD137 抗体在癌症免疫治疗中的最新进展。
Int J Mol Sci. 2019 Apr 12;20(8):1822. doi: 10.3390/ijms20081822.
3
Analysis of the protein-protein interaction networks of differentially expressed genes in pulmonary embolism.肺栓塞中差异表达基因的蛋白质-蛋白质相互作用网络分析

本文引用的文献

1
Regulation of follicular dendritic cell networks by activated T cells: the role of CD137 signaling.活化T细胞对滤泡树突状细胞网络的调节:CD137信号传导的作用
J Immunol. 2005 Jul 15;175(2):884-90. doi: 10.4049/jimmunol.175.2.884.
2
Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines.抗CD137单克隆抗体的给药增强了基于树突状细胞的疫苗的抗肿瘤功效。
Cancer Res. 2004 Nov 15;64(22):8411-9. doi: 10.1158/0008-5472.CAN-04-0590.
3
Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells.
Mol Med Rep. 2015 Apr;11(4):2527-33. doi: 10.3892/mmr.2014.3006. Epub 2014 Nov 26.
4
Targeting costimulatory molecules to improve antitumor immunity.靶向共刺激分子以增强抗肿瘤免疫力。
J Biomed Biotechnol. 2012;2012:926321. doi: 10.1155/2012/926321. Epub 2012 Feb 12.
5
The role of TNF superfamily members in T-cell function and diseases.肿瘤坏死因子超家族成员在T细胞功能及疾病中的作用。
Nat Rev Immunol. 2009 Apr;9(4):271-85. doi: 10.1038/nri2526.
6
IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo.干扰素-γ-吲哚胺-2,3-双加氧酶在体内4-1BB介导的免疫抑制中起主要抑制因子的作用。
J Leukoc Biol. 2009 May;85(5):817-25. doi: 10.1189/jlb.0408246. Epub 2009 Feb 13.
7
Immune regulation and control of regulatory T cells by OX40 and 4-1BB.OX40和4-1BB对调节性T细胞的免疫调节与控制
Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):253-62. doi: 10.1016/j.cytogfr.2008.04.003. Epub 2008 May 27.
8
CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion.基于树突状细胞的加强疫苗接种期间CTLA-4阻断会影响树突状细胞存活和CTL扩增。
J Immune Based Ther Vaccines. 2007 Jul 29;5:9. doi: 10.1186/1476-8518-5-9.
9
Dual immunoregulatory pathways of 4-1BB signaling.4-1BB信号传导的双重免疫调节途径。
J Mol Med (Berl). 2006 Sep;84(9):726-36. doi: 10.1007/s00109-006-0072-2. Epub 2006 Aug 5.
用4-1BB(CD137)刺激可通过诱导供体CD4 + T细胞的活化诱导细胞死亡来抑制慢性移植物抗宿主病。
Blood. 2005 Mar 1;105(5):2206-13. doi: 10.1182/blood-2004-06-2080. Epub 2004 Nov 2.
4
4-1BB-mediated immunotherapy of rheumatoid arthritis.4-1BB介导的类风湿关节炎免疫治疗。
Nat Med. 2004 Oct;10(10):1088-94. doi: 10.1038/nm1107. Epub 2004 Sep 26.
5
CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses.缺乏CD137的小鼠自然杀伤细胞/自然杀伤T细胞数量减少且功能降低,对脂多糖诱导的休克综合征具有抗性,并且白细胞介素-4反应较低。
J Immunol. 2004 Sep 15;173(6):4218-29. doi: 10.4049/jimmunol.173.6.4218.
6
Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.阻断4-1BB(CD137)/4-1BB配体相互作用可提高同种异体移植物的存活率。
Transpl Int. 2004 Aug;17(7):351-61. doi: 10.1007/s00147-004-0726-3. Epub 2004 Jul 31.
7
Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.抗CD137抗体在自身免疫性疾病和癌症治疗中的应用。
Immunol Res. 2004;29(1-3):197-208. doi: 10.1385/IR:29:1-3:197.
8
Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation.自然杀伤细胞对树突状细胞功能的调节:白细胞介素-12与4-1BB激活联合治疗协同作用的潜在机制
J Immunol. 2004 Apr 15;172(8):4779-89. doi: 10.4049/jimmunol.172.8.4779.
9
4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12.4-1BB配体在人树突状细胞上受到调控,并诱导白细胞介素-12的产生。
Cell Immunol. 2003 Nov;226(1):37-44. doi: 10.1016/j.cellimm.2003.11.003.
10
Tumor expression of 4-1BB ligand sustains tumor lytic T cells.4-1BB配体的肿瘤表达维持肿瘤溶解性T细胞。
Cancer Biol Ther. 2003 Sep-Oct;2(5):579-86. doi: 10.4161/cbt.2.5.545.